Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
Authors: C. Assaf, M. Bagot, R. Dummer, M. Duvic, R. Gniadecki, R. Knobler, A. Ranki, P. Schwandt, S. Whittaker
Journal: British Journal of Dermatology (2006)

Journal Article Minimizing adverse side‐effects of oral bexarotene in cutaneous T‐cell lymphoma: an expert opinion Get access C. Assaf, C. Assaf Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Chalid Assaf. E‐mail: chalid.assaf@charite.de Search for other works by this author on: Oxford Academic Google Scholar M. Bagot, M. Bagot Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Search for other works by this author on: Oxford Academic Google Scholar R. Dummer, R. Dummer Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Search for other works by this author on: Oxford Academic Google Scholar M. Duvic, M. Duvic Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Search for other works by this author on: Oxford Academic Google Scholar R. Gniadecki, R. Gniadecki Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Search for other works by this author on: Oxford Academic Google Scholar R. Knobler, R. Knobler Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Search for other works by this author on: Oxford Academic Google Scholar A. Ranki, A. Ranki Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Search for other works by this author on: Oxford Academic Google Scholar P. Schwandt, P. Schwandt Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Search for other works by this author on: Oxford Academic Google Scholar S. Whittaker S. Whittaker Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité–Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany *Department of Dermatology, AP‐HP, Hôpital Henri Mondor, INSERM, U 659, University Paris 12, Créteil 94010, France †Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH‐8091 Zurich, Switzerland ‡Department of Dermatology, University of Texas M.D. Anderson Cancer Center – Box 434, 1515 Holcombe Boulevard, Houston, TX 77030, U.S.A. §Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, DK‐2400 Copenhagen, Denmark ¶Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Währingergürtel 18–20, A‐1090 Vienna, Austria **Skin and Allergy Hospital, Helsinki University Hospital, PO Box 160, 00029 HUS Helsinki, Finland ††Arteriosklerose‐Präventions‐Institut München, Wilbrechtstrasse 95, D‐81477 Munich, Germany ‡‡St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 155, Issue 2, 1 August 2006, Pages 261–266, https://doi.org/10.1111/j.1365-2133.2006.07329.x Published: 01 August 2006 Article history Accepted: 11 February 2006 Published: 01 August 2006